Loading the session
Loading the session
Loading instrument
$64.42
+5.90%Market closedDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 04:44 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
The 4 Nov 2026 gain of 5.9% was 4.3× its average daily move of 1.4% over the past year, and its largest one-day gain since 5 Jun 2026.
Daily closes, split-adjusted · as of 4 Nov 2026
1 month: +14.2% (SPY −1.6%). 3 months: −13.9% (SPY −0.4%). 1 year: −6.7% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: COO, SPY · as of 4 Nov 2026
The 4 Nov 2026 close of $64.42 was 8.2% above its 50-day average ($59.56) and 6.1% below its 200-day average ($68.60). It has closed below the 200-day for 51 sessions, since 25 Aug 2026. The 50-day average crossed below the 200-day on 24 Apr 2026, 134 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Closed at $64.42 on 4 Nov 2026: 28.3% below the 52-week high of $89.83 (5 Dec 2025) and 26.3% above the low of $51.01 (10 Sep 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
9.1M shares were sold short at the 15 Oct 2026 settlement, 4.8% of the 190.2M shares outstanding; covering them would take 2.4 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Price return, split-adjusted
At the 4 Nov 2026 close
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
September 10, 2026
−14.67%August 28, 2025
−12.85%May 30, 2025
−14.61%